Veronica Salib

Arlington

Associate Site Editor at Xtelligent Healthcare Media

Featured in: Favicon

xtelligentmedia.com Favicon

healthitanalytics.com Favicon

pharmanewsintel.com Favicon

techtarget.com

Articles

Understanding biomarker validation, qualification challenges

Jan 7, 2025 | techtarget.com | Veronica Salib

Biomarker validation and qualification challenges might include reproducibility, standardization, regulation, diversity, time, economics and clinical implementation.
2025 life sciences industry outlook: What's next?

Dec 10, 2024 | techtarget.com | Veronica Salib

A 2025 life sciences industry outlook report identifies several focus areas, including digital transformation, competitive pressures, business volatility and evolving customer needs.
Pharmacy closures pose risk for minority communities

Dec 6, 2024 | techtarget.com | Veronica Salib

Ca-ssis/istock via Getty Images A study analyzing trends in pharmacy closures found that closures exceeded pharmacy openings between 2018 and 2021, disproportionately impacting marginalized communities.
Zepbound outperforms Wegovy in weight loss clinical trial

Dec 4, 2024 | techtarget.com | Veronica Salib

A Stockphoto - stock.adobe.com Researchers comparing the safety and efficacy of Zepbound and Wegovy in a phase 3b clinical trial find that Zepbound might achieve better weight loss results than Wegovy.
Anticipating the healthcare reach of GLP-1 receptor agonists

Dec 2, 2024 | techtarget.com | Veronica Salib

Thought leaders at the 2024 WMIF discussed how cost, drug shortages, compounding pharmacies and insurance coverage for GLP-1 receptor agonists will impact the future landscape.
Exploring the secondary prevention of cervical cancer

Nov 25, 2024 | techtarget.com | Veronica Salib

The American Cancer Society estimates that 13,820 new cervical cancer cases will be diagnosed across the United States in 2024, and 4,360 women in America will die of cervical cancer in the same year. Cervical cancer is most often diagnosed in women between the ages of 25 and 44; however, anyone with a cervix might be at risk of cervical cancer.
FDA investigates E. coli outbreak in organic carrots

Nov 21, 2024 | techtarget.com | Veronica Salib

StarLineArts/istock via getty im The FDA is investigating an E. coli outbreak linked to several brands of organic carrots that were recalled by Grimmway Farms for contamination with Shiga toxin-producing E. coli.
Over half of Americans won't get the new COVID-19 vaccine

Nov 20, 2024 | techtarget.com | Veronica Salib

sdecoret - stock.adobe.com Although over half of Americans do not plan to get the new COVID-19 vaccine for a range of reasons, perceptions vary based on political affiliation, age and race.
Revolutionizing women's health technology through innovation

Nov 19, 2024 | techtarget.com | Veronica Salib

As more scientists and innovators work toward addressing the gaps in women's healthcare, women's health technology and the ongoing innovation in tech will be critical tools.
WHO, CDC report a 20% rise in global measles cases

Nov 15, 2024 | techtarget.com | Veronica Salib

The WHO and CDC emphasize the need for greater measles surveillance and targeted vaccination efforts to address the 20% rise in global measles cases from 2022 to 2023.